BASF sells food and health performance ingredients business to Louis Dreyfus Company
Divestment is part of BASF’s strategic portfolio optimization
Divestment is part of BASF’s strategic portfolio optimization
Exploring new opportunities within the fast-growing market of microfluidics
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Harnessing advanced data analysis for early detection, prevention and better outcomes
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
Subscribe To Our Newsletter & Stay Updated